Tran PV, Dellva MA, Tolefson GD, Wentley AL, Beasley CM.Oral olanzapine versus oral haloperidol in the maintenance of schizophrenia and related psychoses. Br J Psychiatry1998;172: 499-505.
2.
Eder-Ischia U, Edenbichler C, Fleischhacker WW.Olanzapine-induced weight gain and disturbances of lipid and glucose metabolism. Essent Psychopharmacol2005;6:112-117.
3.
Adams BB, Mutasim DF.Pustular eruption induced by olanzapine, a novel antipsychotic drug. J Am Acad Dermatol1999; 41:851-853.
4.
Raz A, Bergman R, Eilam O, Yungerman T, Hayek T.A case report of olanzapine-induced hypersensitivity syndrome. Am J Med Sci2001;321:156-158.
5.
Duggal MK, Singh A, Arunabh, Lolis JD, Guzic HJ.Olanzapine-induced vasculitis. Am J Geriatr Pharmacother2005; 3:21-24.
6.
Doyle MK, Guellar ML.Drug-induced vasculitis. Expert Opin Drug Saf2003;2:401-409.
7.
Poon DYH, Law NM.A case of cutaneous leukocytoclastic vasculitis associated with gabapentin. Singapore Med J2003;44: 42-44.
